Loading stock data…
Elanco Animal Health Incorporated (ELAN)
$23.97-0.53 (-2.16%)
Market ClosedLast close Sep 8
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Elanco Animal Health Incorporated in the Healthcare sector is trading at $23.97 with a market capitalization of $11.9B. Wall Street consensus targets $31.21 (14 analysts), implying a +30.2% move over the next 12 months. The stock is currently 14% below its 52-week high of $27.98, remaining 0.9% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +30.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.37B↑ | $1.14B↑ | $1.14B↓ | $1.24B↑ | $1.19B |
| Gross Profit | $785.00M↑ | $589.00M↓ | $607.00M↓ | $713.00M↑ | $684.00M |
| Operating Income | $169.00M↑ | $19.00M↓ | $27.00M↓ | $85.00M↓ | $121.00M |
| Net Income | $57.00M↑ | -$276.00M↓ | -$34.00M↓ | $11.00M↓ | $67.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that p...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$11.92B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-3.72%
Volume
Today's trading volume
3.89M
Recent News
Elanco Director Purchases 40,000 Shares for $936,000
Purchasing 40,000 shares is a bullish signal for shareholders.
3 Stocks Under $50 That Concern Us
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
Elanco celebrates $120 million expansion of Elwood manufacturing facility
ELWOOD, Kan. (News-Press NOW) — Elanco Animal Health recently completed a $120 million expansion of its Elwood manufacturing facility, quadrupling production capacity at a site that company leaders say will play a central role in developing and producing the next generation of animal health treatments. Company, state and federal officials gathered Wednesday to celebrate completion of the ...
2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
Director's Confidence Visible as Elanco Leader Buys 10,000 Shares
Insider buys into strength as the Elanco stock price has outperformed the S&P 500 over the last 12 months.